Refraining from resection in patients with potentially curable gastric carcinoma

被引:3
作者
Gertsen, Emma C. [1 ]
Brenkman, Hylke J. F. [1 ]
Brosens, L. A. A. [2 ]
Luijten, Josianne C. H. B. M. [3 ]
Mohammad, Nadia Haj [4 ]
Verhoeven, Rob H. A. [3 ,5 ]
van Hillegersberg, Richard [1 ]
Ruurda, Jelle P. [1 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[3] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands
[4] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Surg, Nijmegen, Netherlands
来源
EJSO | 2021年 / 47卷 / 05期
关键词
Gastric cancer; Treatment; Gastrectomy; Population-based; SHARED DECISION-MAKING; SPECIALIZATION; MANAGEMENT;
D O I
10.1016/j.ejso.2020.10.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Surgical resection is the cornerstone of curative treatment for gastric cancer. The aim of this study was to evaluate reasons for and patient- and tumor characteristics that are associated with refraining from surgical resection in patients with potentially curable gastric cancer. Materials and methods: Between 2015 and 2017, all patients with potentially curable gastric adenocarcinoma (cT1-4a-x, cN0-3-x, cM0) were included from the Netherlands Cancer Registry (NCR). Patients were divided into a resection (RG) and a no-resection group (nRG). Reasons for not undergoing resection as registered by the NCR were evaluated. Using multivariable logistic regression analyses, patient and tumor characteristics associated with refraining from resection were assessed. Results: Of the 1679 analyzed patients with potentially curable disease, 1127 patients (67%) underwent resection, and 552 patients (33%) did not. Most common registered reasons for refraining from surgery were patient refusal (25%), low performance status (23%), comorbidity and extent of disease (both 10%). Factors associated with not undergoing resection were: age >= 80 years (OR 4.77, [95%CI 2.27-10.06], p < 0.001), low Social-Economic-Status (SES) (OR 2.68 [95%CI 1.31-5.46], p = 0.007), WHO performance status 3-4 (OR 10.48 [95%CI 2.41-45.73], p = 0.002) with several accompanying comorbidities, unclassified Lauren classification (OR 3.93 [95%CI 1.61-9.56], p = 0.003) and overlapping/diffuse tumors (OR 3.51, [95%CI 1.54-8.05], p = 0.003). Conclusion: A third of patients with potentially curable gastric cancer did not undergo resection. Most frequent registered reasons for refraining from surgery were patient refusal, performance status, comorbidity and extent of disease. Additionally, multivariable analyses identified higher age, lower SES, and poor tumor characteristics as associated factors. (C) 2020 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:1062 / 1068
页数:7
相关论文
共 27 条
[1]   Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial [J].
Al-Batran, Salah-Eddin ;
Homann, Nils ;
Pauligk, Claudia ;
Goetze, Thorsten O. ;
Meiler, Johannes ;
Kasper, Stefan ;
Kopp, Hans-Georg ;
Mayer, Frank ;
Haag, Georg Martin ;
Luley, Kim ;
Lindig, Udo ;
Schmiegel, Wolff ;
Pohl, Michael ;
Stoehlmacher, Jan ;
Folprecht, Gunnar ;
Probst, Stephan ;
Prasnikar, Nicole ;
Fischbach, Wolfgang ;
Mahlberg, Rolf ;
Trojan, Joerg ;
Koenigsmann, Michael ;
Martens, Uwe M. ;
Thuss-Patience, Peter ;
Egger, Matthias ;
Block, Andreas ;
Heinemann, Volker ;
Illerhaus, Gerald ;
Moehler, Markus ;
Schenk, Michael ;
Kullmann, Frank ;
Behringer, Dirk M. ;
Heike, Michael ;
Pink, Daniel ;
Teschendorf, Christian ;
Loehr, Carmen ;
Bernhard, Helga ;
Schuch, Gunter ;
Rethwisch, Volker ;
von Weikersthal, Ludwig Fischer ;
Hartmann, Joerg T. ;
Kneba, Michael ;
Daum, Severin ;
Schulmann, Karsten ;
Weniger, Joerg ;
Belle, Sebastian ;
Gaiser, Timo ;
Oduncu, Fuat S. ;
Guentner, Martina ;
Hozaeel, Wael ;
Reichart, Alexander .
LANCET, 2019, 393 (10184) :1948-1957
[2]   Influence of specialization on the management and outcome of patients with pancreatic cancer [J].
Bachmann, MO ;
Alderson, D ;
Peters, TJ ;
Bedford, C ;
Edwards, D ;
Wotton, S ;
Harvey, IM .
BRITISH JOURNAL OF SURGERY, 2003, 90 (02) :171-177
[3]   Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers [J].
Bachmann, MO ;
Alderson, D ;
Edwards, D ;
Wotton, S ;
Bedford, C ;
Peters, TJ ;
Harvey, IM .
BRITISH JOURNAL OF SURGERY, 2002, 89 (07) :914-922
[4]   Shared Decision Making - The Pinnacle of Patient-Centered Care [J].
Barry, Michael J. ;
Edgman-Levitan, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :780-781
[5]   Factors influencing health-related quality of life after gastrectomy for cancer [J].
Brenkman, Hylke J. F. ;
Tegels, Juul J. W. ;
Ruurda, Jelle P. ;
Luyer, Misha D. P. ;
Kouwenhoven, Ewout A. ;
Draaisma, Werner A. ;
van der Peet, Donald L. ;
Wijnhoven, Bas P. L. ;
Stoot, Jan H. M. B. ;
van Hillegersberg, Richard .
GASTRIC CANCER, 2018, 21 (03) :524-532
[6]   Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit [J].
Busweiler, L. A. D. ;
Wijnhoven, B. P. L. ;
Henegouwen, M. I. van Berge ;
Henneman, D. ;
van Grieken, N. C. T. ;
Wouters, M. W. J. M. ;
van Hillegersberg, R. ;
van Sandick, J. W. .
BRITISH JOURNAL OF SURGERY, 2016, 103 (13) :1855-1863
[7]   North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis [J].
Claassen, Y. H. M. ;
Dikken, J. L. ;
Hartgrink, H. H. ;
de Steur, W. O. ;
Slingerland, M. ;
Verhoeven, R. H. A. ;
van Eycken, E. ;
de Schutter, H. ;
Johansson, J. ;
Rouvelas, I ;
Johnson, E. ;
Hjortland, G. O. ;
Jensen, L. S. ;
Larsson, H. J. ;
Allum, W. H. ;
Portielje, J. E. A. ;
Bastiaannet, E. ;
van de Velde, C. J. H. .
EJSO, 2018, 44 (12) :1982-1989
[8]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[9]   Can shared decision-making reduce medical malpractice litigation? A systematic review [J].
Durand, Marie-Anne ;
Moulton, Benjamin ;
Cockle, Elizabeth ;
Mann, Mala ;
Elwyn, Glyn .
BMC HEALTH SERVICES RESEARCH, 2015, 15
[10]  
Earle CC, 2002, CAN J SURG, V45, P438